Amelie Wenz
Assistant with doctoral duties at Department of Pharmaceutical Biosciences; Research; Pharmaceutical Bioinformatics
- E-mail:
- amelie.wenz@uu.se
- Visiting address:
- Biomedicinskt centrum BMC, Husargatan 3
- Postal address:
- Box 591
751 24 UPPSALA
Publications
Recent publications
-
Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
Part of eLIFE, 2024
- DOI for Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
- Download full text (pdf) of Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
-
Heparanase Modulates Chromatin Accessibility
Part of Cells, 2023
- DOI for Heparanase Modulates Chromatin Accessibility
- Download full text (pdf) of Heparanase Modulates Chromatin Accessibility
-
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Part of Cancer Research, p. 4586-4603, 2022
- DOI for Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Download full text (pdf) of Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
All publications
Articles in journal
-
Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
Part of eLIFE, 2024
- DOI for Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
- Download full text (pdf) of Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
-
Heparanase Modulates Chromatin Accessibility
Part of Cells, 2023
- DOI for Heparanase Modulates Chromatin Accessibility
- Download full text (pdf) of Heparanase Modulates Chromatin Accessibility
-
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Part of Cancer Research, p. 4586-4603, 2022
- DOI for Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
- Download full text (pdf) of Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma